The India Hemodialysis and Peritoneal Dialysis Market was valued at $3120 Million in 2024 and projected to reach to $4960 Million by 2029, representing a compound annual growth rate of CAGR 9.7%. India's hemodialysis and peritoneal dialysis market is positioned for accelerated growth through 2029, driven by rising chronic kidney disease prevalence, expanding healthcare infrastructure, and increasing patient awareness.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India's hemodialysis and peritoneal dialysis market is projected to grow from USD 3,120 million in 2024 to USD 4,960 million by 2029, representing a robust 9.7% CAGR that significantly outpaces the global growth rate of 6.5%.
India faces an escalating chronic kidney disease epidemic driven by high prevalence of diabetes and hypertension, creating substantial demand for dialysis services across urban and emerging healthcare centers.
Government initiatives and private sector expansion are strengthening dialysis infrastructure across India, improving accessibility in tier-2 and tier-3 cities and rural regions with growing patient populations.
India's substantial population with increasing CKD incidence provides a vast addressable market for dialysis providers, manufacturers, and healthcare stakeholders seeking growth opportunities in South Asia.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOME HEMODIALYSIS SERVICES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 6.5% from 2024 to 2029 |
| Largest Segment | CONVENTIONAL LONG-TERM HEMODIALYSIS (Modality) |
| Market Size Base Year (Billions) | ~USD 92.11 (2024) |
| Revenue Forecast (Billions) | ~USD 126.2 (2029) |
| Segments Covered | Product & Service, Type, Material, Flux, Modality, Disease Indication, End User, Modality 2022–2029 |
8 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based drug administration in long-term acute care hospitals,Oral drug administration and regimen management in inpatient rehabilitation facilities,Topical, inhaled, and other specialized administration routes in contract rehabilitation services, |
| NOLATO | Sweden | Public Company | Medical components and assemblies,Pharmaceutical primary packaging,Labware and TreffLab products, |
| SHIMADZU CORPORATION | Japan | Public Company | Analytical and Measuring Instruments,Medical Systems,Vacuum and Industrial Machinery, |
| MERIT MEDICAL | United States | Public Company | Cardiovascular – Peripheral Intervention (angiography, drainage, delivery, embolotherapy),Cardiovascular – Cardiac Intervention (access, angiography, EP/CRM, fluid and hemodynamic management),Access & Safety (micropuncture kits, needles, sheaths, guide wires, safety products), |
| STERIS CORPORATION | United States | Public Company | Healthcare (hospital capital equipment, chemistries, and services),Applied Sterilization Technologies (contract sterilization and related services),Life Sciences (pharma/biopharma detergents, disinfectants, sterilizers, and services), |
| FRESENIUS MEDICAL CARE AG | Germany | Public Company | Care Delivery (outpatient and hospital dialysis services),Hemodialysis machines and disposables,Peritoneal dialysis systems and solutions, |
| BAXTER | United States | Public Company | Medical Products & Therapies (IV, infusion, parenteral nutrition, renal and related),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding), |
| DAVITA INC. | United States | Public Company | In-center outpatient dialysis services,Hospital inpatient dialysis services,Home-based hemodialysis and peritoneal dialysis, |
| NIKKISO CO., LTD. | Japan | Public Company | Industrial pumps and systems (including cryogenic),Cryogenic heat transfer and process equipment,Precision equipment and industrial systems, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes), |
| ASAHI KASEI CORPORATION | Japan | Public Company | Advanced materials for electronics and energy (semiconductor materials, Hipore, Celgard, optical fiber, sensors),Homes, construction systems, and real estate,Healthcare (pharma, devices, virus removal filters, data systems), |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO CORPORATION | Japan | Public Company | Dialysis and renal consumables,Injection and infusion disposables,Cardiovascular and interventional devices, |
| ROCKWELL MEDICAL, INC. | United States | Public Company | Acid concentrates (Citrapure, RenalPure, Dri-Sate),Bicarbonate concentrates and cartridges (RenalPure, Sterilyte),Dialysis kits and integrated concentrate systems, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (needles, syringes, vascular access, sharps, specimen collection),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems), |
Kindred Healthcare Inc. is a United States-based private healthcare company founded in 1985, operating with a workforce of 64,200 employees.
Nolato is a Swedish public company founded in 1938 with 5,607 employees, specializing in medical and healthcare-related manufacturing.
Shimadzu Corporation is a Japanese public company established in 1875 with 14,649 employees, operating in the medical and analytical instrumentation sectors.
Merit Medical is a United States-based public company founded in 1987 with 7,500 employees, specializing in medical devices and healthcare products.
Steris Corporation is a United States-based public company founded in 1985 with 17,937 employees, providing sterilization and healthcare solutions.
Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, operating as a major provider of dialysis and renal care services.
Baxter is a United States-based public company founded in 1931 with 37,500 employees, specializing in medical devices, pharmaceuticals, and healthcare products.
DaVita Inc. is a United States-based public company founded in 1994 with 78,000 employees, operating as a leading provider of dialysis and kidney care services.
Nikkiso Co., Ltd. is a Japanese public company founded in 1950 with 8,120 employees, manufacturing medical devices and healthcare equipment.
Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology and healthcare devices.
Asahi Kasei Corporation is a Japanese public company founded in 1922 with 47,895 employees, operating in healthcare, chemicals, and materials sectors.
Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees, specializing in medical devices and healthcare products.
Nipro Corporation is a Japanese public company founded in 1954, specializing in medical devices and healthcare solutions.
Rockwell Medical, Inc. is a United States-based public company founded in 1996 with 157 employees, specializing in medical devices and healthcare solutions.
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, operating as a global leader in medical devices and healthcare products.
India's hemodialysis and peritoneal dialysis market was valued at USD 3,120 million in 2024 and is expected to reach USD 4,960 million by 2029.
India's dialysis market is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2029, significantly exceeding the global average.
Key drivers include rising prevalence of chronic kidney disease, increasing diabetes and hypertension rates, an aging population, expanding healthcare infrastructure, and growing awareness of renal replacement therapies in India.
India's dialysis market includes both multinational dialysis equipment manufacturers and domestic players, creating a competitive environment that fosters innovation and affordability.
By 2029, India is expected to see increased adoption of both hemodialysis and peritoneal dialysis, improved accessibility in urban and semi-urban areas, and continued technological innovation driven by competitive dynamics.
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
The research methodology for estimating and forecasting the data center cooling CDU pumps market begins with gathering data on key vendors' revenues by doing secondary research. The secondary research process involves consulting a range of secondary sources, including Hoover's, Bloomberg Businessweek, Factiva, the World Bank, and industry-specific journals. These secondary sources encompass annual reports, press releases, investor presentations, white papers, certified publications, articles from recognized authors, regulatory notifications, trade directories, and databases. Also, vendor offerings are taken into consideration to inform market segmentation.
Primary research for this study was conducted with leading participants across the hemodialysis and peritoneal dialysis value chain. On the supply side, discussions were held with project managers, regional sales managers, product directors, vice presidents of marketing, chief executive officers, and chief information officers at hemodialysis machine manufacturers, dialyzer manufacturers, PD cycler suppliers, consumables providers, water treatment system vendors, and dialysis service operators. On the demand side, interviews were conducted with nephrologists, dialysis center directors, renal care procurement managers, hospital administrators, home dialysis program coordinators, and clinical nursing staff responsible for patient training in home hemodialysis and peritoneal dialysis settings. These interviews were used to validate market size estimates, corroborate segmentation assumptions, and capture the latest commercial dynamics across in-center, home, and acute dialysis care settings.

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The total size of the hemodialysis & peritoneal dialysis market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

After arriving at the overall market size using both the market size estimation processes described above, the total market was split into several segments and subsegments. To complete the overall market estimation process and ascertain exact statistics for all segments and subsegments, data triangulation and market breakdowns were applied wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the hemodialysis and peritoneal dialysis markets.
The global hemodialysis and peritoneal dialysis market encompasses the revenues generated from the sale and provision of products, equipment, and services used to deliver renal replacement therapy to patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as patients with acute kidney injury (AKI) requiring short-term dialysis support. On the hemodialysis side, the market includes center-use and home-use hemodialysis machines, hemodialysis consumables and supplies (dialyzers, bloodlines and tubing sets, concentrates and dialysates, vascular access products, and other consumables), water treatment systems for dialysis centers (central and portable water disinfection systems), and in-center and home hemodialysis services.
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information
Full forecast, segment splits, and company analysis for all Hemodialysis and Peritoneal Dialysis Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report